Back to search

Article

Recurrent Breast Cancer Cells Depend on <i>De novo</i> Pyrimidine Biosynthesis to Suppress Ferroptosis

2025-11-17

Abstract excerpt

Breast cancer recurrence remains a major clinical challenge, often associated with therapy resistance and altered metabolic states. To define metabolic vulnerabilities of recurrent disease, we performed a CRISPR knockout screen targeting 421 metabolic genes in paired primary and recurrent HER2-driven breast cancer cell lines. While both primary and recurrent tumors shared dependencies on core metabolic pathways, r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
271eaa0b-a55c-53d8-8036-60f8531cb940
DOI
10.1101/2025.11.17.688927
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Recurrent Breast Cancer Cells Depend on <i>De novo</i> Pyrimidine Biosynthesis to Suppress FerroptosisDOI 10.1101/2025.11.17.688927
Select a neighboring publication to make it the new centre.